Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P190013/S001

DBP-1400-ABE and DBP-2003- ABE

Aed Battery Exchange, LLC · Decision date Oct 28, 2025

FDA DECISIONP190013/S001

What did the FDA approve?

FDA records P190013/S001 as a supplement to PMA P190013, with the supplement type “Normal 180 Day Track”. The recorded decision is approval, dated Oct 28, 2025.

FDA approval order statement

approval for two new models of re-celled automated external defibrillator (AED) batteries, models DBP-1400-ABE and DBP-2003-ABE.
Regulatory pathway
PMA supplement
Supplement type
Normal 180 Day Track
Clinical specialty
Cardiovascular
Decision date
Oct 28, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P190013/S001
Regulatory pathway
PMA supplement
Product code
MKJ
Decision code
APPR
Decision date
Oct 28, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Automated external defibrillators (non-wearable).

Product code
MKJ
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P190013/S001 received

    Application receipt date recorded by FDA.

  2. P190013/S001 · FDA decision

    Normal 180 Day Track

Timeline entries are records held by MedtechLedger for P190013. View FDA’s full supplement list.

Related devices and submissions

Explore the linked device profile

Other records with product code MKJ

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Aed Battery Exchange, LLC

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
1000 Brown St., Suite #206, Wauconda, IL, 60084

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records